Royal Biologics – Trademark Portfolio
Entity Type: 03
Royal Biologics holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 12 trademarks are registered and 2 are pending. Notable registered marks include MAGNUS, MAXX BMC, MAXX PRP, BIO-REIGN, and BIOINCYTE. The owner is based in Hackensack, NJ.
401 Hackensack Avenue, Suite 604
Hackensack, NJ 07601
Showing of trademarks Trademarks
Trademark Classifications
Royal Biologics's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Royal Biologics have?
Royal Biologics has 19 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 pending, 5 abandoned.
What trademark classes does Royal Biologics file in?
Royal Biologics files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Royal Biologics's most well-known trademarks?
Royal Biologics's registered trademark portfolio includes well-known marks such as MAGNUS, MAXX BMC, MAXX PRP, BIO-REIGN, and BIOINCYTE. These are among 12 currently registered trademarks in the portfolio.
What is Royal Biologics's trademark registration success rate?
Royal Biologics has a 71% trademark registration rate, with 12 out of 17 resolved applications resulting in successful registration. Currently, 2 applications are pending review.